SCHEMBL22346709

SCHEMBL22346709

COC(=O)c1[nH]c2ccc(Br)cc2c1C=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.54
MAPT P10636 6/20 0.54
MEN1 O00255 5/20 0.54
ALDH1A1 P00352 5/20 0.54
CYP1A2 P05177 4/20 0.54
CYP2C19 P33261 4/20 0.54
CYP2C9 P11712 3/20 0.54
GAA P10253 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 1/20 0.54
ALOX12 P18054 1/20 0.54
NR4A2 P43354 1/20 0.51
PRNP P04156 1/20 0.47
PPARG P37231 1/20 0.47
HIF1A Q16665 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RXFP1 Q9HBX9 1/20 0.47
NR2E3 Q9Y5X4 1/20 0.47
NCOR2 Q9Y618 1/20 0.47
POLB P06746 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22346720 0.89 ALOX15 (0.53) KMT2AMAPTMEN1ALDH1A1CYP1A2
SCHEMBL333829 0.85 ALOX15 (0.62) KMT2AMAPTMEN1ALDH1A1CYP1A2
SCHEMBL5392425 0.84 ALDH1A1 (0.55) KMT2AMAPTMEN1ALDH1A1GAA
SCHEMBL29953042 0.83 ALOX15 (0.60) KMT2AMAPTMEN1ALDH1A1CYP1A2
SCHEMBL29951480 0.83 KMT2A (0.56) KMT2AMAPTMEN1ALDH1A1GAA
SCHEMBL15329883 0.83 TUBB4A (0.57) KMT2AMAPTMEN1ALDH1A1GAA
SCHEMBL5402454 0.83 ALOX15 (0.60) KMT2AMAPTMEN1ALDH1A1CYP1A2
SCHEMBL20570224 0.82 MAPT (0.58) KMT2AMAPTMEN1ALDH1A1CYP1A2
SCHEMBL29955514 0.82 RXFP1 (0.58) KMT2AMAPTMEN1ALDH1A1CYP1A2
SCHEMBL5574039 0.81 ALOX15 (0.61) KMT2AMAPTMEN1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3924056-A1 THIENO[3,2-B] PYRROLE[3,2-D]PYRIDAZINONE DERIVATIVES AND THEIR USE AS PKM2 DERIVATIVES FOR THE TREATMENT OF CANCER, OBESITY AND DIABETES RELATED DISORDERS Agios Pharmaceuticals, Inc. (US) 2021-12-22 EP disclosed
WO-2020167976-A1 THIENO[3,2-B] PYRROLE[3,2-D]PYRIDAZINONE DERIVATIVES AND THEIR USE AS PKM2 DERIVATIVES FOR THE TREATMENT OF CANCER, OBESITY AND DIABETES RELATED DISORDERS AGIOS PHARMACEUTICALS, INC. (US) 2020-08-20 WO disclosed